Cytarabine | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Cytarabine
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Cytarabine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

33 API Suppliers, 16 USDMF, 5 CEP/COS, 2 JDMF, 1 EU WC, 1 KDMF, 3 NDC API, 18 Listed Suppliers, $ API Reference Price

33 API Suppliers
16 USDMF
5 CEP/COS
2 JDMF
1 EU WC
1 KDMF
3 NDC API
18 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

411 Drugs in Development

411 Drugs in Development

FINISHED DOSAGE FORMULATIONS

118 FDF Dossiers, 31 FDA Orange Book, 37 Europe, 4 Canada, 2 Australia, 10 South Africa, 34 Listed Dossiers

118 FDF Dossiers
31 FDA Orange Book
37 Europe
4 Canada
2 Australia
10 South Africa
34 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 DKSH, 1 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 2 Kirsch Pharma, 5 Actylis, 1 Finar, 1 Gangwal Chemicals, 4 Nippon Fine Chemical

1 DKSH
1 Nanjing Well Pharmaceutical
1 Shanghai Minbiotech
1 Pfanstiehl
2 Kirsch Pharma
5 Actylis
1 Finar
1 Gangwal Chemicals
4 Nippon Fine Chemical

EXCIPIENTS BY APPLICATIONS

8 Parenteral, 5 Topical, 4 Thickeners and Stabilizers, 3 Solubilizers, 3 Emulsifying Agents, 2 Coating Systems & Additives, 2 Surfactant & Foaming Agents, 2 Taste Masking, 1 Film Formers & Plasticizers, 1 Co-Processed Excipients

8 Parenteral
5 Topical
4 Thickeners and Stabilizers
3 Solubilizers
3 Emulsifying Agents
2 Coating Systems & Additives
2 Surfactant & Foaming Agents
2 Taste Masking
1 Film Formers & Plasticizers
1 Co-Processed Excipients

DIGITAL CONTENT

53 News #PharmaBuzz

53 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 26 Regulatory FDF Prices, 6 Annual Reports

4 US Medicaid Prescriptions
26 Regulatory FDF Prices
6 Annual Reports

MARKET PLACE

6 APIs, 4 FDF Dossiers

6 APIs
4 FDF Dossiers

PATENTS & EXCLUSIVITIES

10 US Patents, 1 US Exclusivities, 5 Health Canada Patents

10 US Patents
1 US Exclusivities
5 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 Others

2 EDQM
1 Others

$ API Ref.Price (USD/KG) : 1,392 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

5 All

01 5Torys LLP

filter Patent Reset all filters

5 All

01 12462369

02 12467064

03 12564542

04 12678332

05 12852777

filter Product Reset all filters

5 All

01 5DAUNORUBICIN | CYTARABINE

filter Dosage Reset all filters

5 All

01 5POWDER

filter Exp Date Reset all filters

5 All

01 12022-10-03

02 12022-11-13

03 12025-04-22

04 12028-02-15

05 12032-10-15

Product Main Page

01

Torys LLP

Daunorubicin, Cytarabine

Peptide Process CMC

Not Confirmed

Torys LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-04-22

Date Granted : 2012-11-27

Daunorubicin, Cytarabine

Brand Name : VYXEOS

Patent Number : 2564542

Filing Date : 2005-04-22

Strength per Unit : 44mg / vial / 100mg / vial

Dosage Form : POWDER

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2025-04-22

Date Granted : 2012-11-27

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Torys LLP

Daunorubicin, Cytarabine

Peptide Process CMC

Not Confirmed

Torys LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-02-15

Date Granted : 2015-06-02

Daunorubicin, Cytarabine

Brand Name : VYXEOS

Patent Number : 2678332

Filing Date : 2008-02-15

Strength per Unit : 44mg / vial / 100mg / vial

Dosage Form : POWDER

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2028-02-15

Date Granted : 2015-06-02

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Torys LLP

Daunorubicin, Cytarabine

Peptide Process CMC

Not Confirmed

Torys LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-10-15

Date Granted : 2020-10-27

Daunorubicin, Cytarabine

Brand Name : VYXEOS

Patent Number : 2852777

Filing Date : 2012-10-15

Strength per Unit : 44mg / vial / 100mg / vial

Dosage Form : POWDER

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2032-10-15

Date Granted : 2020-10-27

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Torys LLP

Daunorubicin, Cytarabine

Peptide Process CMC

Not Confirmed

Torys LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-11-13

Date Granted : 2011-02-08

Daunorubicin, Cytarabine

Brand Name : VYXEOS

Patent Number : 2467064

Filing Date : 2002-11-13

Strength per Unit : 44mg / vial / 100mg / vial

Dosage Form : POWDER

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2022-11-13

Date Granted : 2011-02-08

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Torys LLP

Daunorubicin, Cytarabine

Peptide Process CMC

Not Confirmed

Torys LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-10-03

Date Granted : 2009-12-22

Daunorubicin, Cytarabine

Brand Name : VYXEOS

Patent Number : 2462369

Filing Date : 2002-10-03

Strength per Unit : 44mg / vial / 100mg / vial

Dosage Form : POWDER

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2022-10-03

Date Granted : 2009-12-22

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!